KIT
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y791 | Sugiyama | POTEF A26C1B | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPVLLTEATLN |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y851 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | QVWPEANQHFSKEIDDEANSyFQRIYNHPPHPTMSVDEVLE |
| A6NMY6 | Y147 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00170 | Y202 | Sugiyama | AIP XAP2 | IHQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPE |
| O00170 | Y203 | Sugiyama | AIP XAP2 | HQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPEW |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00401 | Y256 | Sugiyama | WASL | FDMCGIsEAQLKDRETSKVIyDFIEKTGGVEAVKNELRRQA |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O14639 | Y383 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | sIPGsPGHtIyAKVDNEILDyKDLAAIPKVKAIYDIERPDL |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43615 | T198 | Sugiyama | TIMM44 MIMT44 TIM44 | ALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKF |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60341 | Y135 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | RAKVEyREMDEsLANLsEDEyysEEERNAKAEKEKKLPPPP |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60664 | Y235 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AtsLDGFDVAsVQQQRQEQSyFVRLGsLSERLRQHAyEHsL |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60763 | Y655 | Sugiyama | USO1 VDP | DKKEEEVKKTLEQHDNIVTHyKNMIREQDLQLEELRQQVST |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75391 | Y163 | Sugiyama | SPAG7 | QRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKDAAHML |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | T132 | Sugiyama | ENDOD1 KIAA0830 | INEAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSD |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95433 | Y323 | Sugiyama | AHSA1 C14orf3 HSPC322 | EGRGIPAPEEERTRQGWQRyyFEGIKQTFGYGARLF_____ |
| O95817 | Y240 | Sugiyama | BAG3 BIS | AAQPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPL |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00533 | Y1197 | Sugiyama | EGFR ERBB ERBB1 HER1 | FPKEAKPNGIFKGstAENAEyLRVAPQsSEFIGA_______ |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P02545 | Y45 | Sugiyama | LMNA LMN1 | RItRLQEKEDLQELNDRLAVyIDRVRsLETENAGLRLRItE |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04080 | T51 | Sugiyama | CSTB CST6 STFB | ENKKFPVFKAVSFKSQVVAGtNyFIKVHVGDEDFVHLRVFQ |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04083 | Y21 | Sugiyama | ANXA1 ANX1 LPC1 | MAMVsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPt |
| P04181 | Y50 | Sugiyama | OAT | TKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyL |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04920 | Y73 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | EAGsRGGEEPGRsYGEEDFEyHRQSSHHIHHPLSTHLPPDA |
| P05067 | Y308 | Sugiyama | APP A4 AD1 | REVCSEQAETGPCRAMISRWyFDVTEGKCAPFFyGGCGGNR |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P06730 | Y34 | Sugiyama | EIF4E EIF4EL1 EIF4F | PPttEEEKtEsNQEVANPEHyIKHPLQNRWALWFFKNDKsK |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y131 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ILGVsLAVCKAGAVEKGVPLyRHIADLAGNsEVILPVPAFN |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07195 | Y240 | Sugiyama | LDHB | GTDNDSENWKEVHKMVVEsAyEVIKLKGYTNWAIGLSVADL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07355 | Y147 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | Y106 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAES |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07437 | Y59 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDsVRsG |
| P07686 | Y463 | Sugiyama | HEXB HCC7 | VILSAPWYLDLISYGQDWRKyyKVEPLDFGGtQKQKQLFIG |
| P07686 | Y464 | Sugiyama | HEXB HCC7 | ILSAPWYLDLISYGQDWRKyyKVEPLDFGGtQKQKQLFIGG |
| P07711 | Y311 | Sugiyama | CTSL CTSL1 | DNNKYWLVKNsWGEEWGMGGyVKMAKDRRNHCGIAsAAsyP |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y434 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KNLVKKCLELFtELAEDKENyKKFyEQFSKNIKLGIHEDsQ |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08670 | Y291 | Sugiyama | VIM | DVRQQyEsVAAKNLQEAEEWyKSKFADLsEAANRNNDALRQ |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09874 | Y794 | Sugiyama | PARP1 ADPRT PPOL | AySLLRGGsDDssKDPIDVNyEKLKTDIKVVDRDSEEAEII |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG38 | Y791 | Sugiyama | POTEI | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y754 | Sugiyama | POTEJ | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10721 | S715 | Sugiyama | KIT SCFR | EDHAEAALyKNLLHSKESSCsDsTNEyMDMKPGVsyVVPTK |
| P10721 | S717 | Sugiyama | KIT SCFR | HAEAALyKNLLHSKESSCsDsTNEyMDMKPGVsyVVPTKAD |
| P10721 | S729 | Sugiyama | KIT SCFR | SKESSCsDsTNEyMDMKPGVsyVVPTKADKRRsVRIGsyIE |
| P10721 | S821 | Sugiyama | KIT SCFR | THGRITKICDFGLARDIKNDsNyVVKGNARLPVKWMAPESI |
| P10721 | S937 | Sugiyama | KIT SCFR | FKQIVQLIEKQISEstNHIysNLANCsPNRQKPVVDHSVRI |
| P10721 | S943 | Sugiyama | KIT SCFR | LIEKQISEstNHIysNLANCsPNRQKPVVDHSVRINsVGst |
| P10721 | S959 | Sugiyama | KIT SCFR | LANCsPNRQKPVVDHSVRINsVGstAsSSQPLLVHDDV___ |
| P10721 | S962 | Sugiyama | KIT SCFR | CsPNRQKPVVDHSVRINsVGstAsSSQPLLVHDDV______ |
| P10721 | T607 | Sugiyama | KIT SCFR | NRLSFGKTLGAGAFGKVVEAtAyGLIKSDAAMTVAVKMLKP |
| P10721 | T932 | Sugiyama | KIT SCFR | LKRPTFKQIVQLIEKQISEstNHIysNLANCsPNRQKPVVD |
| P10721 | Y547 | EPSD|PSP|Sugiyama | KIT SCFR | IGFVIVAGMMCIIVMILTYKyLQKPMyEVQWKVVEEINGNN |
| P10721 | Y553 | EPSD|PSP|Sugiyama | KIT SCFR | AGMMCIIVMILTYKyLQKPMyEVQWKVVEEINGNNyVyIDP |
| P10721 | Y568 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | KIT SCFR | LQKPMyEVQWKVVEEINGNNyVyIDPTQLPYDHKWEFPRNR |
| P10721 | Y570 | SIGNOR|ELM|iPTMNet|EPSD|PSP | KIT SCFR | KPMyEVQWKVVEEINGNNyVyIDPTQLPYDHKWEFPRNRLS |
| P10721 | Y609 | Sugiyama | KIT SCFR | LSFGKTLGAGAFGKVVEAtAyGLIKSDAAMTVAVKMLKPSA |
| P10721 | Y703 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | KIT SCFR | RRKRDSFICSKQEDHAEAALyKNLLHSKESSCsDsTNEyMD |
| P10721 | Y721 | EPSD|PSP|Sugiyama | KIT SCFR | ALyKNLLHSKESSCsDsTNEyMDMKPGVsyVVPTKADKRRs |
| P10721 | Y730 | Sugiyama | KIT SCFR | KESSCsDsTNEyMDMKPGVsyVVPTKADKRRsVRIGsyIER |
| P10721 | Y747 | Sugiyama | KIT SCFR | GVsyVVPTKADKRRsVRIGsyIERDVTPAIMEDDELALDLE |
| P10721 | Y823 | SIGNOR|EPSD|PSP|Sugiyama | KIT SCFR | GRITKICDFGLARDIKNDsNyVVKGNARLPVKWMAPESIFN |
| P10721 | Y900 | EPSD|Sugiyama | KIT SCFR | YKMIKEGFRMLsPEHAPAEMyDIMKTCWDADPLKRPTFKQI |
| P10721 | Y936 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | KIT SCFR | TFKQIVQLIEKQISEstNHIysNLANCsPNRQKPVVDHSVR |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11233 | Y153 | Sugiyama | RALA RAL | DKRQVsVEEAKNRAEQWNVNyVETSAKTRANVDKVFFDLMR |
| P11413 | Y118 | Sugiyama | G6PD | LEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGsQANRLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12004 | Y249 | Sugiyama | PCNA | MSADVPLVVEYKIADMGHLKyyLAPKIEDEEGs________ |
| P12004 | Y250 | Sugiyama | PCNA | SADVPLVVEYKIADMGHLKyyLAPKIEDEEGs_________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P12956 | Y30 | Sugiyama | XRCC6 G22P1 | tEGDEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKAMFE |
| P13073 | Y38 | Sugiyama | COX4I1 COX4 | SVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKHLSAS |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13693 | Y18 | Sugiyama | TPT1 | ___MIIYRDLIsHDEMFsDIyKIREIADGLCLEVEGKMVSR |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13929 | Y131 | Sugiyama | ENO3 | ILGVSLAVCKAGAAEKGVPLyRHIADLAGNPDLILPVPAFN |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P13987 | Y87 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | FEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTSL |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y429 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IKLYVRRVFITDDFHDMMPKyLNFVKGVVDsDDLPLNVsRE |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14625 | Y677 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDM |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P14927 | Y90 | Sugiyama | UQCRB UQBP | NLKHQILPKEQWTKyEEENFyLEPyLKEVIRERKEREEWAK |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15328 | Y80 | Sugiyama | FOLR1 FOLR | WRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHF |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18084 | Y509 | Sugiyama | ITGB5 | CSPGYLGTRCECQDGENQsVyQNLCREAEGKPLCSGRGDCS |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y372 | Sugiyama | NELFE RD RDBP | NsPKGCHRDKRTQIVysDDVyKENLVDGF____________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y433 | Sugiyama | NCL | FEDAAEIRLVSKDGKSKGIAyIEFKTEADAEKTFEEKQGtE |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P20810 | Y618 | Sugiyama | CAST | KAKAEHRDKLGERDDTIPPEyRHLLDDNGQDKPVKPPTKKS |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T91 | Sugiyama | CFL1 CFL | FVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24844 | Y156 | Sugiyama | MYL9 MLC2 MRLC1 MYRL2 | DEEVDEMyREAPIDKKGNFNyVEFTRILKHGAKDKDD____ |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y45 | Sugiyama | MCM3 | DEEDQGIyQsKVRELIsDNQyRLIVNVNDLRRKNEKRANRL |
| P25208 | Y58 | Sugiyama | NFYB HAP3 | SMNDHEDTNGSKESFREQDIyLPIANVARIMKNAIPQTGKI |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30622 | Y108 | Sugiyama | CLIP1 CYLN1 RSN | AGIVLDEPIGKNDGSVAGVRyFQCEPLKGIFTRPSKLTRKV |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y213 | Sugiyama | SFN HME1 | LAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNLtLWTAD |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32004 | Y310 | Sugiyama | L1CAM CAML1 MIC5 | YQNHNKTLQLLKVGEEDDGEyRCLAENSLGSARHAYYVTVE |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P35232 | Y259 | PSP | PHB1 PHB | RKLEAAEDIAyQLSRSRNItyLPAGQSVLLQLPQ_______ |
| P35606 | Y824 | Sugiyama | COPB2 | AFVVEEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQP |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P36954 | Y54 | Sugiyama | POLR2I | ILLyACRNCDYQQEADNSCIyVNKITHEVDELtQIIADVsQ |
| P37108 | T29 | Sugiyama | SRP14 | FLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVEGF |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P38919 | Y54 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VDVTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIK |
| P38919 | Y56 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIKGR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | Y131 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | KLENLKsLDLFNCEVtNLNDyRENVFKLLPQLtyLDGyDRD |
| P40763 | Y176 | Sugiyama | STAT3 APRF | QDLEQKMKVVENLQDDFDFNyKTLKsQGDMQDLNGNNQsVT |
| P41219 | Y287 | Sugiyama | PRPH NEF4 PRPH1 | DIRAQYESIAAKNLQEAEEWyKSKYADLSDAANRNHEALRQ |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P42224 | Y701 | SIGNOR|EPSD | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P43121 | Y222 | Sugiyama | MCAM MUC18 | YTLQSILKAQLVKEDKDAQFyCELNYRLPSGNHMKEsREVT |
| P43243 | Y214 | Sugiyama | MATR3 KIAA0723 | PsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDs |
| P43243 | Y243 | Sugiyama | MATR3 KIAA0723 | RLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPLQER |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P45974 | Y849 | Sugiyama | USP5 ISOT | WVIYNDQKVCASEKPPKDLGyIyFyQRVAS___________ |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47712 | Y535 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | sFDDDELDAAVADPDEFERIyEPLDVKSKKIHVVDSGLTFN |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49023 | Y409 | Sugiyama | PXN | EEIGSRNFFERDGQPYCEKDyHNLFsPRCYYCNGPILDKVV |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P49588 | Y295 | Sugiyama | AARS1 AARS | GARPYTGKVGAEDADGIDMAyRVLADHARTITVALADGGRP |
| P49591 | Y248 | Sugiyama | SARS1 SARS SERS | FMRKEVMQEVAQLsQFDEELyKVIGKGSEKSDDNSYDEKYL |
| P49773 | Y109 | Sugiyama | HINT1 HINT PKCI1 PRKCNH1 | GLNKGYRMVVNEGsDGGQsVyHVHLHVLGGRQMHWPPG___ |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50402 | Y99 | Sugiyama | EMD EDMD STA | KEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPSRAVRQ |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50990 | Y426 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | KRLVPGGGAtEIELAKQItsyGETCPGLEQyAIKKFAEAFE |
| P50990 | Y436 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EIELAKQItsyGETCPGLEQyAIKKFAEAFEAIPRALAENS |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52655 | Y365 | Sugiyama | GTF2A1 TF2A1 | SKNKWKFHLKDGIMNLNGRDyIFSKAIGDAEW_________ |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55196 | Y1497 | Sugiyama | AFDN AF6 MLLT4 | VIRELQPQQQPRTIERRDLQyItVsKEELssGDsLsPDPWK |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P56192 | Y718 | Sugiyama | MARS1 MARS | KVRIRDALRSILtISRHGNQyIQVNEPWKRIKGSEADRQRA |
| P56945 | Y234 | Sugiyama | BCAR1 CAS CASS1 CRKAS | VPtRVGQGyVyEAAQPEQDEyDIPRHLLAPGPQDIyDVPPV |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60709 | Y91 | Sugiyama | ACTB | IEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAPLN |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y48 | Sugiyama | EIF4A1 DDX2A EIF4A | NEIVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIK |
| P60842 | Y50 | Sugiyama | EIF4A1 DDX2A EIF4A | IVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIKGy |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61024 | Y19 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | __MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLVPKTHLMs |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61158 | S232 | Sugiyama | ACTR3 ARP3 | EVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKW |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61313 | Y62 | Sugiyama | RPL15 EC45 TCBAP0781 | PTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGAtyG |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63261 | Y91 | Sugiyama | ACTG1 ACTG | IEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAPLN |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y93 | Sugiyama | ACTC1 ACTC | IEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAPLN |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y93 | Sugiyama | ACTA1 ACTA | IEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAPLN |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P80303 | Y389 | Sugiyama | NUCB2 NEFA | QKQKEELQRQHDQLEAQKLEyHQVIQQMEQKKLQQGIPPSG |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P84103 | Y32 | Sugiyama | SRSF3 SFRS3 SRP20 | VyVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVE |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00341 | Y40 | Sugiyama | HDLBP HBP VGL | VPQQIKVAtLNsEEEsDPPtyKDAFPPLPEKAACLESAQEP |
| Q00534 | Y13 | Sugiyama | CDK6 CDKN6 | ________MEKDGLCRADQQyECVAEIGEGAyGKVFKARDL |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00610 | Y900 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACVA |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q02809 | Y434 | Sugiyama | PLOD1 LLH PLOD | LWSNFWGALSADGYYARSEDyVDIVQGRRVGVWNVPYISNI |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | Y1128 | Sugiyama | TJP1 ZO1 | NQHsQDLDSRQHPEESSERGyFPRFEEPAPLsyDsRPRYEQ |
| Q07157 | Y1191 | Sugiyama | TJP1 ZO1 | LRPEAQPHPsAGPKPAEsKQyFEQysRsyEQVPPQGFTSRA |
| Q07157 | Y1355 | Sugiyama | TJP1 ZO1 | KPPEDIVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAHI |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07955 | Y37 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | RIyVGNLPPDIRtKDIEDVFyKYGAIRDIDLKNRRGGPPFA |
| Q07955 | Y82 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | EDPRDAEDAVYGRDGyDYDGyRLRVEFPRSGRGTGRGGGGG |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12996 | Y708 | Sugiyama | CSTF3 | NEDsDEDEEKGAVVPPVHDIyRARQQKRIR___________ |
| Q13017 | Y1109 | Sugiyama | ARHGAP5 RHOGAP5 | DNyAEPIDTIFKQKGYsDEIyVVPDDsQNRIKIRNsFVNNt |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13144 | Y495 | Sugiyama | EIF2B5 EIF2BE | KDKVKMKGYNPAEVGAAGKGyLWKAAGMNMEEEEELQQNLW |
| Q13228 | T38 | Sugiyama | SELENBP1 SBP | AMKGPREEIVyLPCIyRNtGtEAPDyLATVDVDPKsPQyCQ |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13228 | Y43 | Sugiyama | SELENBP1 SBP | REEIVyLPCIyRNtGtEAPDyLATVDVDPKsPQyCQVIHRL |
| Q13239 | Y120 | SIGNOR|PSP | SLA SLAP SLAP1 | LPDTKVGSFMIRESETKKGFySLSVRHRQVKHYRIFRLPNN |
| Q13239 | Y258 | SIGNOR|PSP | SLA SLAP SLAP1 | SLTSEDNTSFDRKKKSISLMyGGsKRKssFFSsPPyFED__ |
| Q13239 | Y273 | SIGNOR|PSP | SLA SLAP SLAP1 | SISLMyGGsKRKssFFSsPPyFED_________________ |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13242 | Y214 | Sugiyama | SRSF9 SFRS9 SRP30C | RsRSGsRGRDsPyQsRGsPHyFsPFRPy_____________ |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13356 | Y212 | Sugiyama | PPIL2 | DPSYYLKNTNAETRETLQELyKEFKGDEILAATMKAPEKKK |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13480 | Y659 | Sugiyama | GAB1 | PPRKQKssGsGssVADERVDyVVVDQQKTLALKSTREAWTD |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | Y106 | Sugiyama | TUBB3 TUBB4 | RPDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECEN |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13573 | Y292 | Sugiyama | SNW1 SKIIP SKIP | GRGLQTVHINENFAKLAEALyIADRKAREAVEMRAQVERKM |
| Q13573 | Y430 | Sugiyama | SNW1 SKIIP SKIP | RLFNQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRP |
| Q13573 | Y433 | Sugiyama | SNW1 SKIIP SKIP | NQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRPSKN |
| Q13596 | Y162 | Sugiyama | SNX1 | QFDLTVGITDPEKIGDGMNAyVAyKVTTQTsLPLFRSKQFA |
| Q13619 | Y259 | Sugiyama | CUL4A | TNCLYAAEGQRLMQEREVPEyLNHVSKRLEEEGDRVITYLD |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | Y106 | Sugiyama | TUBB2A TUBB2 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14240 | Y49 | Sugiyama | EIF4A2 DDX2B EIF4F | NEIVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIK |
| Q14240 | Y51 | Sugiyama | EIF4A2 DDX2B EIF4F | IVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIKGy |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y289 | Sugiyama | CTTN EMS1 | FGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDySKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14247 | Y453 | Sugiyama | CTTN EMS1 | yRGPVsGtEPEPVysMEAADyREASSQQGLAYATEAVyESA |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14566 | Y598 | Sugiyama | MCM6 | FARQFKPKISKESEDFIVEQyKHLRQRDGSGVTKSSWRITV |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14677 | Y114 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | SERVVTSAREHIyDLRSLENyHFVDEHGKDQGINIRQKVKE |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y489 | Sugiyama | GANAB G2AN KIAA0088 | PHIKVDSGyRVHEELRNLGLyVKtRDGSDyEGWCWPGSAGY |
| Q14697 | Y60 | Sugiyama | GANAB G2AN KIAA0088 | tCEEssFCKRQRsIRPGLsPyRALLDSLQLGPDSLTVHLIH |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15181 | Y17 | Sugiyama | PPA1 IOPPP PP | ____MSGFSTEERAAPFsLEyRVFLKNEKGQyIsPFHDIPI |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15293 | Y140 | Sugiyama | RCN1 RCN | VAKVWKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssD |
| Q15293 | Y147 | Sugiyama | RCN1 RCN | YDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKM |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y228 | Sugiyama | RCN1 RCN | VLEtLEDIDKNGDGFVDQDEyIADMFSHEENGPEPDWVLSE |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15555 | Y268 | Sugiyama | MAPRE2 RP1 | NEQVHsLKLALEGVEKERDFyFGKLREIELLCQEHGQENDD |
| Q15631 | Y210 | Sugiyama | TSN | sLRKRYDGLKYDVKKVEEVVyDLSIRGFNKETAAACVEK__ |
| Q15650 | Y289 | Sugiyama | TRIP4 RQT4 | LLEFDRtsIRRtQVIDDESDyFASDSNQWLSKLERETLQKR |
| Q15650 | Y345 | Sugiyama | TRIP4 RQT4 | KVTIDFAGRKILEEENsLAEyHSRLDETIQAIANGTLNQPL |
| Q15691 | Y217 | Sugiyama | MAPRE1 | MQQVNVLKLtVEDLEKERDFyFGKLRNIELICQENEGENDP |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q32MZ4 | Y597 | Sugiyama | LRRFIP1 GCF2 TRIP | KKKKsPVPVETLKDVKKELtyQNTDLsEIKEEEQVKstDRK |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5SW79 | Y364 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | QMLWERTEEDsKsIKsDVPVyLKRLKGNKHDDGtQsDsENA |
| Q5T200 | Y592 | Sugiyama | ZC3H13 KIAA0853 | EKGSRGsRGsQIDsHSSNSNyHDSWETRSSYPERDRYPERD |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6NVY1 | Y247 | Sugiyama | HIBCH | EDLLALKsPSKENIAsVLENyHtESKIDRDKSFILEEHMDK |
| Q6QNY0 | Y40 | Sugiyama | BLOC1S3 BLOS3 | GEAtEtDsERsAsssEEEELyLGPSGPTRGRPTGLRVAGEA |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y791 | Sugiyama | POTEE A26C1A POTE2 | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | Y453 | Sugiyama | FIP1L1 FIP1 RHE | HLPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDR |
| Q6ZSR9 | Y28 | Sugiyama | None | LYPDPSRVPGTKTQNNLESDyLARDGPSSNSSFHSSEEEGT |
| Q71RC2 | Y425 | Sugiyama | LARP4 PP13296 | SRNFPAERHNPTVTGHQEQtyLQKETSTLQVEQNGDYGRGR |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7RTV0 | Y100 | Sugiyama | PHF5A | KDRDGCPKIVNLGSsKTDLFyERKKYGFKKR__________ |
| Q7Z5J4 | Y305 | Sugiyama | RAI1 KIAA1820 | QQQQQQQALQSRHHAQETLHyQNLAKYQHYGQQGQGYCQPD |
| Q86SX6 | Y88 | Sugiyama | GLRX5 C14orf87 | GFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSNWPT |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86XP3 | Y160 | Sugiyama | DDX42 | ERKNVKGIRDDIEEEDDQEAyFRYMAENPtAGVVQEEEEDN |
| Q8IV50 | T210 | Sugiyama | LYSMD2 | STQAAKKLKEESRDEEsPyAtSLyHs_______________ |
| Q8IWX8 | Y894 | Sugiyama | CHERP DAN26 SCAF6 | GDVRDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDE |
| Q8IWX8 | Y897 | Sugiyama | CHERP DAN26 SCAF6 | RDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDECK_ |
| Q8IWX8 | Y903 | Sugiyama | CHERP DAN26 SCAF6 | YKGVGVALDDPyENyRRNKsysFIARMKARDECK_______ |
| Q8IXH6 | Y211 | Sugiyama | TP53INP2 C20orf110 DOR PINH | RQNRARESRPRRSKNQSsFIyQPCQRQFNY___________ |
| Q8IY92 | T1561 | Sugiyama | SLX4 BTBD12 KIAA1784 KIAA1987 | GLEtPKGANRKKNLPPKVPItPMPQYSIMEtPVLKKELDRF |
| Q8IY92 | T1571 | Sugiyama | SLX4 BTBD12 KIAA1784 KIAA1987 | KKNLPPKVPItPMPQYSIMEtPVLKKELDRFGVRPLPKRQM |
| Q8IZP0 | Y23 | Sugiyama | ABI1 SSH3BP1 | ELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATDK |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8N684 | Y451 | Sugiyama | CPSF7 | SRESSRRHRDLLHNEDRHDDyFQERNREHERHRDRERDRHH |
| Q8N6H7 | Y278 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | QAADAKKQAEESMVASMRLAyQELQIDRKKEEKKLQNLEGK |
| Q8N7H5 | Y311 | Sugiyama | PAF1 PD2 | IAREYNWNVKNKASKGyEENyFFIFREGDGVyyNELETRVR |
| Q8NBF2 | Y39 | Sugiyama | NHLRC2 | TSLEYALLDAVTQQEKDSLVyQyLQKVDGWEQDLSVPEFPE |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8NDI1 | Y585 | Sugiyama | EHBP1 KIAA0903 NACSIN | TYKVGNYETDTNssVDQEKFyAELSDLKREPELQQPISGAV |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TD19 | Y845 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PDsPsPLsAAFsEsEKDTLPyEELQGLKVAsEAPLEHKPQV |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WUA2 | Y401 | Sugiyama | PPIL4 | TSKKHKKKTHHCsEEKEDEDyMPIKNTNQDIYREMGFGHYE |
| Q8WVC0 | Y374 | Sugiyama | LEO1 RDL | PETRIEVEIPKVNTDLGNDLyFVKLPNFLSVEPRPFDPQYY |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WX93 | Y731 | Sugiyama | PALLD KIAA0992 CGI-151 | PMSALASRsAPAMQssGsFNyARPKQFIAAQNLGPAsGHGt |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92796 | S678 | Sugiyama | DLG3 KIAA1232 | HTTRPRRDNEVDGQDyHFVVsREQMEKDIQDNKFIEAGQFN |
| Q92796 | Y673 | Sugiyama | DLG3 KIAA1232 | GSCVPHTTRPRRDNEVDGQDyHFVVsREQMEKDIQDNKFIE |
| Q92878 | Y1162 | Sugiyama | RAD50 | EINKIIRDLWRSTYRGQDIEyIEIRSDADENVSASDKRRNY |
| Q92945 | Y626 | Sugiyama | KHSRP FUBP2 | EPPQPPPTGQSDYTKAWEEyyKKIGQQPQQPGAPPQQDytK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96AE4 | Y590 | Sugiyama | FUBP1 | DQQNPAPAGQVDYTKAWEEyyKKMGQAVPAPTGAPPGGQPD |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96F86 | Y258 | Sugiyama | EDC3 LSM16 YJDC YJEFN2 PP844 | NERPTRYRHDENILESEPIVyRRIIVPHNVSKEFCTDSGLV |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HE7 | Y178 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | HDDSSDNFCEADDIQsPEAEyVDLLLNPERYTGYKGPDAWK |
| Q96IK1 | Y82 | Sugiyama | BOD1 FAM44B | RGLFDSFRRDCLADVDTKPAyQNLRQKVDNFVStHLDKQEW |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96NB3 | Y315 | Sugiyama | ZNF830 CCDC16 | EDEEGRLDRQIGEIDEQIECyRRVEKLRNRQDEIKNKLKEI |
| Q96QC0 | Y512 | Sugiyama | PPP1R10 CAT53 FB19 PNUTS | GILQELFLNKESPHEPDPEPyEPIPPKLIPLDEECSMDETP |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99470 | Y69 | Sugiyama | SDF2 | GSGSGQQSVTGVTSVDDSNSyWRIRGKSATVCERGTPIKCG |
| Q99614 | Y212 | Sugiyama | TTC1 TPR1 | ILRRAELYEKTDKLDEALEDyKSILEKDPSIHQAREACMRL |
| Q99614 | Y96 | Sugiyama | TTC1 TPR1 | ADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQKRREES |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y544 | Sugiyama | ACO2 | LEAPDADELPKGEFDPGQDtyQHPPKDSsGQHVDVsPtsQR |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BPX3 | Y929 | Sugiyama | NCAPG CAPG NYMEL3 | QDATLTTTTFQNEDEKNKEVyMtPLRGVKATQASKSTQLKT |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRK5 | Y162 | Sugiyama | SDF4 CAB45 PSEC0034 | sKTHFRAVDPDGDGHVsWDEyKVKFLASKGHSEKEVADAIR |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | Y106 | Sugiyama | TUBB2B | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q9BW71 | Y111 | Sugiyama | HIRIP3 | RKRFRFNsEsEsGsEASSPDyFGPPAKNGVAAEVsPAKEEN |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BYX7 | Y91 | Sugiyama | POTEKP ACTBL3 FKSG30 | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| Q9C0C2 | Y1122 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | FsPGQQDWsRDFCIEASERsyQFGIIGNDRVsGAGFsPssK |
| Q9GZY6 | Y110 | EPSD|PSP | LAT2 LAB NTAL WBS15 WBSCR15 WBSCR5 HSPC046 | PASSRyQNFSKGsRHGsEEAyIDPIAMEyyNWGRFSKPPED |
| Q9GZY6 | Y118 | EPSD|PSP | LAT2 LAB NTAL WBS15 WBSCR15 WBSCR5 HSPC046 | FSKGsRHGsEEAyIDPIAMEyyNWGRFSKPPEDDDANsyEN |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H2H8 | T140 | Sugiyama | PPIL3 | KVIDGLETLDELEKLPVNEKtyRPLNDVHIKDItIHANPFA |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HC35 | Y226 | Sugiyama | EML4 C2orf2 EMAPL4 | PKVTKTADKHKDVIINQEGEyIKMFMRGRPItMFIPSDVDN |
| Q9HCG8 | Y45 | Sugiyama | CWC22 KIAA1604 NCM | RNssPEDRYEEQERsPRDRDyFDYsRsDYEHSRRGRsYDsS |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9NP61 | Y432 | Sugiyama | ARFGAP3 ARFGAP1 | ENTDEAQKKFGNVKAIssDMyFGRQsQADYETRARLERLsA |
| Q9NPQ8 | Y446 | Sugiyama | RIC8A | MAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVEEKPPN |
| Q9NQW7 | Y588 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | QTKMIDVDSLTDKECDWLNNyHLtCRDVIGKELQKQGRQEA |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NZB2 | Y9 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | ____________MGVQGFQDyIEKHCPsAVVPVELQKLARG |
| Q9UBQ7 | Y255 | Sugiyama | GRHPR GLXR MSTP035 | KETAVFINISRGDVVNQDDLyQALAsGKIAAAGLDVtsPEP |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UFG5 | Y63 | Sugiyama | C19orf25 | EDPPVPFRMMEDAEAPGEQLyQQSRAYVAANQRLQQAGNVL |
| Q9UGY1 | Y30 | Sugiyama | NOL12 | DGDDRRPRLVLsFDEEKRREyLTGFHKRKVERKKAAIEEIK |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UIQ6 | Y70 | Sugiyama | LNPEP OTASE | GsRLLVRGLGEHEMEEDEEDyEssAKLLGMsFMNRssGLRN |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UKY7 | Y244 | Sugiyama | CDV3 H41 | NRGRDEVSKNQALKLQLDNQyAVLENQKSSHSQYN______ |
| Q9ULF5 | Y596 | Sugiyama | SLC39A10 KIAA1265 ZIP10 | RLNEtELtDLEGQQEsPPKNyLCIEEEKIIDHsHsDGLHtI |
| Q9UMS0 | Y194 | Sugiyama | NFU1 HIRIP5 CGI-33 | KELLDTRIRPTVQEDGGDVIyKGFEDGIVQLKLQGSCTSCP |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UNP9 | Y143 | Sugiyama | PPIE CYP33 | KAETQEGEPIAKKARSNPQVyMDIKIGNKPAGRIQMLLRSD |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UPQ0 | Y446 | Sugiyama | LIMCH1 KIAA1102 | LHEAYKNARsQEEAEGILQQyIERFTISEAVLERLEMPKIL |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9Y281 | T91 | Sugiyama | CFL2 | FVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESAPL |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W2 | Y124 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | YKELRKLEVEYEQKRAQLSQyFDAVKNAQHVEVESIPLPDM |
| Q9Y3C1 | Y118 | Sugiyama | NOP16 CGI-117 HSPC111 | EAEASLPEKKGNTLSRDLIDyVRYMVENHGEDYKAMARDEK |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3P9 | Y472 | Sugiyama | RABGAP1 HSPC094 | FFLKLKQIKQRERKNNTDTLyEVVCLESESERERRKTTAsP |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y490 | Y127 | Sugiyama | TLN1 KIAA1027 TLN | TVTDMLMTICARIGITNHDEysLVRELMEEKKEEItGtLRK |
| Q9Y4H2 | Y919 | Sugiyama | IRS2 | PSLPSMHEYPLPPEPKsPGEyINIDFGEPGARLsPPAPPLL |
| Q9Y5Q8 | Y393 | Sugiyama | GTF3C5 CDABP0017 | SGtsGARKPASSKYKLKDSVyIFREGALPPYRQMFYQLCDL |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.851252e-11 | 10.733 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.655370e-09 | 8.576 | 1 | 1 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.848111e-09 | 8.164 | 1 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.561592e-08 | 7.448 | 1 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.307340e-08 | 7.275 | 1 | 1 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.723116e-08 | 7.012 | 1 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.389602e-07 | 6.857 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.558615e-07 | 6.807 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.029762e-07 | 6.395 | 1 | 1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.397040e-07 | 6.268 | 1 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.148826e-06 | 5.940 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.680930e-06 | 5.774 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.842069e-06 | 5.546 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.648052e-06 | 5.438 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.226127e-05 | 4.911 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.222424e-05 | 4.913 | 1 | 1 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.695382e-05 | 4.771 | 1 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.695382e-05 | 4.771 | 1 | 1 |
| Signal Transduction | R-HSA-162582 | 1.791392e-05 | 4.747 | 1 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.491272e-05 | 4.604 | 1 | 1 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.358467e-05 | 4.474 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.688435e-05 | 4.433 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.779950e-05 | 4.423 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.863362e-05 | 4.313 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.288417e-05 | 4.277 | 1 | 1 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.490286e-05 | 4.260 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 5.998215e-05 | 4.222 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.052646e-05 | 4.152 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.017437e-04 | 3.992 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.298876e-04 | 3.886 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.320365e-04 | 3.879 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.474940e-04 | 3.831 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.474940e-04 | 3.831 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.632050e-04 | 3.787 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 2.006983e-04 | 3.697 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.479335e-04 | 3.606 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.030435e-04 | 3.518 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.243943e-04 | 3.489 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.034328e-04 | 3.518 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.304032e-04 | 3.366 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.304032e-04 | 3.366 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.164222e-04 | 3.380 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.304032e-04 | 3.366 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.962603e-04 | 3.304 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.332534e-04 | 3.273 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.332534e-04 | 3.273 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.257191e-04 | 3.279 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.332534e-04 | 3.273 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.506227e-04 | 3.187 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.506227e-04 | 3.187 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.540124e-04 | 3.184 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.832908e-04 | 3.106 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.832908e-04 | 3.106 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.249713e-04 | 3.084 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.336801e-04 | 3.030 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.007679e-03 | 2.997 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.007679e-03 | 2.997 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.170379e-03 | 2.932 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.280435e-03 | 2.893 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.392198e-03 | 2.856 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.448385e-03 | 2.839 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.448385e-03 | 2.839 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.701321e-03 | 2.769 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.777549e-03 | 2.750 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.070689e-03 | 2.684 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.072067e-03 | 2.684 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.920903e-03 | 2.716 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.070689e-03 | 2.684 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.193098e-03 | 2.659 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.199635e-03 | 2.658 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.398682e-03 | 2.620 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.479265e-03 | 2.606 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.798205e-03 | 2.553 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.798205e-03 | 2.553 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.798205e-03 | 2.553 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.779926e-03 | 2.556 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.628586e-03 | 2.440 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.628586e-03 | 2.440 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.446337e-03 | 2.463 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.700513e-03 | 2.432 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.818745e-03 | 2.418 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.446337e-03 | 2.463 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.628586e-03 | 2.440 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.202629e-03 | 2.376 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.344629e-03 | 2.362 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.615555e-03 | 2.336 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.052196e-03 | 2.297 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.615555e-03 | 2.336 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.137188e-03 | 2.289 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.615555e-03 | 2.336 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.588735e-03 | 2.253 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.588735e-03 | 2.253 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.588735e-03 | 2.253 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.588735e-03 | 2.253 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.998080e-03 | 2.222 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.998080e-03 | 2.222 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.306887e-03 | 2.275 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.673884e-03 | 2.246 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.673884e-03 | 2.246 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.036909e-03 | 2.219 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.221290e-03 | 2.206 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.093189e-02 | 1.961 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.093189e-02 | 1.961 | 1 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.093189e-02 | 1.961 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.093189e-02 | 1.961 | 1 | 1 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.093189e-02 | 1.961 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.093189e-02 | 1.961 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.093189e-02 | 1.961 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.093189e-02 | 1.961 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.093189e-02 | 1.961 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.093189e-02 | 1.961 | 1 | 1 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.093189e-02 | 1.961 | 1 | 1 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.093189e-02 | 1.961 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.093189e-02 | 1.961 | 1 | 1 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.093189e-02 | 1.961 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.093189e-02 | 1.961 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.093189e-02 | 1.961 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.093189e-02 | 1.961 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.093189e-02 | 1.961 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.093189e-02 | 1.961 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.093189e-02 | 1.961 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.093189e-02 | 1.961 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.093189e-02 | 1.961 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.093189e-02 | 1.961 | 1 | 1 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.093189e-02 | 1.961 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.093189e-02 | 1.961 | 1 | 1 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.093189e-02 | 1.961 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.093189e-02 | 1.961 | 1 | 1 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.093189e-02 | 1.961 | 1 | 1 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.713996e-03 | 2.173 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.713996e-03 | 2.173 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.713996e-03 | 2.173 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.713996e-03 | 2.173 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.713996e-03 | 2.173 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.243895e-03 | 2.034 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 9.243895e-03 | 2.034 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.064424e-02 | 1.973 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.042995e-03 | 2.152 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.603350e-03 | 2.119 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.189336e-03 | 2.087 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.363344e-03 | 2.196 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.028780e-02 | 1.988 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.933103e-03 | 2.101 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.243895e-03 | 2.034 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.968068e-03 | 2.157 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.713996e-03 | 2.173 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.079439e-02 | 1.967 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.171570e-03 | 2.088 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.042995e-03 | 2.152 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.603350e-03 | 2.119 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.403134e-03 | 2.027 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 6.713996e-03 | 2.173 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.018302e-02 | 1.992 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.178019e-03 | 2.144 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.074657e-02 | 1.969 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.801207e-03 | 2.055 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.439198e-03 | 2.025 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.064424e-02 | 1.973 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.785905e-03 | 2.109 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.059791e-02 | 1.975 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.059791e-02 | 1.975 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.980033e-03 | 2.047 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.079439e-02 | 1.967 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.151198e-02 | 1.939 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.151198e-02 | 1.939 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.151198e-02 | 1.939 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.188641e-02 | 1.925 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.213206e-02 | 1.916 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.221490e-02 | 1.913 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.225645e-02 | 1.912 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.225645e-02 | 1.912 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.260414e-02 | 1.899 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.302797e-02 | 1.885 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.302797e-02 | 1.885 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.370528e-02 | 1.863 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.382666e-02 | 1.859 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.435921e-02 | 1.843 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.512474e-02 | 1.820 | 1 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.536189e-02 | 1.814 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.550606e-02 | 1.809 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.550606e-02 | 1.809 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.638696e-02 | 1.786 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.638696e-02 | 1.786 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.685613e-02 | 1.773 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.729544e-02 | 1.762 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.783862e-02 | 1.749 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.174494e-02 | 1.663 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.225345e-02 | 1.653 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.891733e-02 | 1.723 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.081228e-02 | 1.682 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.120632e-02 | 1.674 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.120632e-02 | 1.674 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.919540e-02 | 1.717 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.919540e-02 | 1.717 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.120632e-02 | 1.674 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.798156e-02 | 1.745 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.278286e-02 | 1.642 | 1 | 1 |
| Innate Immune System | R-HSA-168249 | 2.395765e-02 | 1.621 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.278286e-02 | 1.642 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.823157e-02 | 1.739 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.823157e-02 | 1.739 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.216581e-02 | 1.654 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.437593e-02 | 1.613 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.443109e-02 | 1.612 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.443109e-02 | 1.612 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.443109e-02 | 1.612 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.482720e-02 | 1.605 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.482720e-02 | 1.605 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.524483e-02 | 1.598 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.694347e-02 | 1.570 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.694347e-02 | 1.570 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.694347e-02 | 1.570 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.771513e-02 | 1.557 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.771513e-02 | 1.557 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.790573e-02 | 1.554 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.911932e-02 | 1.536 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.036051e-02 | 1.518 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.036051e-02 | 1.518 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.054594e-02 | 1.515 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.054594e-02 | 1.515 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.054594e-02 | 1.515 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.122608e-02 | 1.505 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.162923e-02 | 1.500 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.244044e-02 | 1.489 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.244044e-02 | 1.489 | 1 | 1 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.244044e-02 | 1.489 | 1 | 1 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.244044e-02 | 1.489 | 1 | 1 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.292541e-02 | 1.482 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.370606e-02 | 1.472 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.370606e-02 | 1.472 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.370606e-02 | 1.472 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.370606e-02 | 1.472 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.424896e-02 | 1.465 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.424896e-02 | 1.465 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.424896e-02 | 1.465 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 3.559980e-02 | 1.449 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.609239e-02 | 1.443 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.609239e-02 | 1.443 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.838289e-02 | 1.416 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.301965e-02 | 1.366 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.301965e-02 | 1.366 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.301965e-02 | 1.366 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.301965e-02 | 1.366 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.348384e-02 | 1.272 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.348384e-02 | 1.272 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.348384e-02 | 1.272 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.348384e-02 | 1.272 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.348384e-02 | 1.272 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.362425e-02 | 1.360 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.168164e-02 | 1.287 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.558688e-02 | 1.255 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.894006e-02 | 1.310 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.275935e-02 | 1.369 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.894006e-02 | 1.310 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.058250e-02 | 1.296 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.348384e-02 | 1.272 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.981493e-02 | 1.400 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.730569e-02 | 1.242 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.730569e-02 | 1.242 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.437278e-02 | 1.353 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.732455e-02 | 1.242 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.894006e-02 | 1.310 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.732455e-02 | 1.242 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.904954e-02 | 1.229 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.105312e-02 | 1.387 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.503562e-02 | 1.259 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.013944e-02 | 1.300 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.549458e-02 | 1.342 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.894006e-02 | 1.310 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.981493e-02 | 1.400 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.275935e-02 | 1.369 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.558688e-02 | 1.255 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.168164e-02 | 1.287 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.986946e-02 | 1.223 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.022294e-02 | 1.220 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.022294e-02 | 1.220 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.094344e-02 | 1.215 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.202835e-02 | 1.207 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.261154e-02 | 1.203 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.261154e-02 | 1.203 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.312419e-02 | 1.200 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.383425e-02 | 1.195 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.383425e-02 | 1.195 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 6.383425e-02 | 1.195 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.627125e-02 | 1.179 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.920868e-02 | 1.160 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.920868e-02 | 1.160 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.977896e-02 | 1.156 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.002697e-02 | 1.155 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.121084e-02 | 1.147 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.265774e-02 | 1.139 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.347647e-02 | 1.134 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.387695e-02 | 1.131 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.387695e-02 | 1.131 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.387695e-02 | 1.131 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.407210e-02 | 1.130 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.407210e-02 | 1.130 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.407210e-02 | 1.130 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 7.407210e-02 | 1.130 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.407210e-02 | 1.130 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.542750e-02 | 1.122 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.583672e-02 | 1.120 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.583672e-02 | 1.120 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.781936e-02 | 1.109 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.181655e-02 | 1.087 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.390222e-02 | 1.076 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.390222e-02 | 1.076 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.419862e-02 | 1.075 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.419862e-02 | 1.075 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.419862e-02 | 1.075 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.419862e-02 | 1.075 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.470072e-02 | 1.072 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.507168e-02 | 1.070 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.731161e-02 | 1.059 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.836556e-02 | 1.054 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.954600e-02 | 1.048 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.231841e-02 | 1.035 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.366670e-02 | 1.028 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.421501e-02 | 1.026 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.421501e-02 | 1.026 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.421501e-02 | 1.026 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.041225e-01 | 0.982 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.041225e-01 | 0.982 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.041225e-01 | 0.982 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.041225e-01 | 0.982 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.139221e-01 | 0.943 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.236152e-01 | 0.908 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.332029e-01 | 0.875 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.520664e-01 | 0.818 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.613445e-01 | 0.792 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.613445e-01 | 0.792 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.705217e-01 | 0.768 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.795990e-01 | 0.746 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.795990e-01 | 0.746 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.885775e-01 | 0.725 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.885775e-01 | 0.725 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.885775e-01 | 0.725 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.019043e-01 | 0.992 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.195589e-01 | 0.922 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.041225e-01 | 0.982 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.520664e-01 | 0.818 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.195589e-01 | 0.922 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.195589e-01 | 0.922 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.705217e-01 | 0.768 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.019043e-01 | 0.992 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.195589e-01 | 0.922 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.291641e-01 | 0.889 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.139221e-01 | 0.943 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.365815e-01 | 0.865 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.365815e-01 | 0.865 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.024121e-01 | 0.990 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.124073e-01 | 0.949 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.139221e-01 | 0.943 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.426862e-01 | 0.846 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 1.426862e-01 | 0.846 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.613445e-01 | 0.792 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 1.613445e-01 | 0.792 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.885775e-01 | 0.725 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 1.683734e-01 | 0.774 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.416402e-01 | 0.849 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.957462e-02 | 1.002 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.139221e-01 | 0.943 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.705217e-01 | 0.768 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.236152e-01 | 0.908 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.761641e-01 | 0.754 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.041225e-01 | 0.982 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.613445e-01 | 0.792 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 1.581530e-01 | 0.801 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.159689e-01 | 0.936 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.019043e-01 | 0.992 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.340928e-01 | 0.873 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.195092e-01 | 0.923 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.795990e-01 | 0.746 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.613445e-01 | 0.792 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.705217e-01 | 0.768 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.416402e-01 | 0.849 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.622965e-01 | 0.790 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.124073e-01 | 0.949 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.236152e-01 | 0.908 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.885775e-01 | 0.725 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.426862e-01 | 0.846 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.795990e-01 | 0.746 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.885775e-01 | 0.725 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.218969e-01 | 0.914 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.849345e-01 | 0.733 | 1 | 0 |
| TCR signaling | R-HSA-202403 | 1.518374e-01 | 0.819 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.865735e-01 | 0.729 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.539438e-02 | 1.020 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.289756e-01 | 0.889 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.840108e-01 | 0.735 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.840108e-01 | 0.735 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.171392e-01 | 0.931 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.795990e-01 | 0.746 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.291641e-01 | 0.889 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.311759e-01 | 0.882 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.139221e-01 | 0.943 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.071418e-01 | 0.970 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.302379e-01 | 0.885 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.702800e-01 | 0.769 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.871350e-01 | 0.728 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.055652e-01 | 0.976 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.810965e-01 | 0.742 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.208140e-01 | 0.918 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.093836e-01 | 0.961 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.846751e-02 | 1.007 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.547224e-01 | 0.810 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.019043e-01 | 0.992 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.665305e-02 | 1.015 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.267247e-01 | 0.897 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.623115e-01 | 0.790 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.623115e-01 | 0.790 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.426862e-01 | 0.846 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.967191e-02 | 1.001 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.124073e-01 | 0.949 | 1 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.622965e-01 | 0.790 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.783747e-01 | 0.749 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.599520e-01 | 0.796 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.865735e-01 | 0.729 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.268202e-01 | 0.897 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.441417e-01 | 0.841 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.919074e-01 | 0.717 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.919074e-01 | 0.717 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.920937e-01 | 0.716 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.974583e-01 | 0.705 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.974583e-01 | 0.705 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.974583e-01 | 0.705 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.974583e-01 | 0.705 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.974583e-01 | 0.705 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.974583e-01 | 0.705 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.974583e-01 | 0.705 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.974583e-01 | 0.705 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.974583e-01 | 0.705 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.993583e-01 | 0.700 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.004502e-01 | 0.698 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.004502e-01 | 0.698 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.004502e-01 | 0.698 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.047347e-01 | 0.689 | 1 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.062424e-01 | 0.686 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.062424e-01 | 0.686 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.062424e-01 | 0.686 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.078272e-01 | 0.682 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.118295e-01 | 0.674 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.118295e-01 | 0.674 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.127339e-01 | 0.672 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.149310e-01 | 0.668 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.149310e-01 | 0.668 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 2.149310e-01 | 0.668 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.158394e-01 | 0.666 | 1 | 1 |
| Reproduction | R-HSA-1474165 | 2.174122e-01 | 0.663 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.235249e-01 | 0.651 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.235249e-01 | 0.651 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.235249e-01 | 0.651 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.235249e-01 | 0.651 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.235249e-01 | 0.651 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.235249e-01 | 0.651 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.319426e-01 | 0.635 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.319426e-01 | 0.635 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.320254e-01 | 0.634 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.320254e-01 | 0.634 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.320254e-01 | 0.634 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 2.320254e-01 | 0.634 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 2.320254e-01 | 0.634 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 2.320254e-01 | 0.634 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.320254e-01 | 0.634 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.320254e-01 | 0.634 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.320254e-01 | 0.634 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.337315e-01 | 0.631 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.377598e-01 | 0.624 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.377598e-01 | 0.624 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.404332e-01 | 0.619 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.404332e-01 | 0.619 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.404332e-01 | 0.619 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.404332e-01 | 0.619 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.404332e-01 | 0.619 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.404332e-01 | 0.619 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.404332e-01 | 0.619 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.440698e-01 | 0.612 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.487496e-01 | 0.604 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.487496e-01 | 0.604 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.521698e-01 | 0.598 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.548572e-01 | 0.594 | 1 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.569754e-01 | 0.590 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.569754e-01 | 0.590 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.569754e-01 | 0.590 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.569754e-01 | 0.590 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.569754e-01 | 0.590 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.646620e-01 | 0.577 | 1 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.651116e-01 | 0.577 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.651116e-01 | 0.577 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.651116e-01 | 0.577 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.651116e-01 | 0.577 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.698136e-01 | 0.569 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.724418e-01 | 0.565 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.727204e-01 | 0.564 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.731592e-01 | 0.564 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.731592e-01 | 0.564 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.731592e-01 | 0.564 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.805490e-01 | 0.552 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.811192e-01 | 0.551 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.811192e-01 | 0.551 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.816710e-01 | 0.550 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.838628e-01 | 0.547 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.846432e-01 | 0.546 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.876181e-01 | 0.541 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.889925e-01 | 0.539 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.889925e-01 | 0.539 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.889925e-01 | 0.539 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.889925e-01 | 0.539 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.889925e-01 | 0.539 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.889925e-01 | 0.539 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.889925e-01 | 0.539 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.905956e-01 | 0.537 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.905956e-01 | 0.537 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.935753e-01 | 0.532 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.967801e-01 | 0.528 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.967801e-01 | 0.528 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.967801e-01 | 0.528 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.007805e-01 | 0.522 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.025264e-01 | 0.519 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.044829e-01 | 0.516 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.044829e-01 | 0.516 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 3.044829e-01 | 0.516 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.044829e-01 | 0.516 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 3.044829e-01 | 0.516 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.044829e-01 | 0.516 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.048171e-01 | 0.516 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.058871e-01 | 0.514 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.088496e-01 | 0.510 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.121017e-01 | 0.506 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.121017e-01 | 0.506 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.196376e-01 | 0.495 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.270913e-01 | 0.485 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.270913e-01 | 0.485 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.344639e-01 | 0.476 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.344639e-01 | 0.476 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.344639e-01 | 0.476 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.409140e-01 | 0.467 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.409140e-01 | 0.467 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.417561e-01 | 0.466 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.417561e-01 | 0.466 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.417561e-01 | 0.466 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.417561e-01 | 0.466 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.417561e-01 | 0.466 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.429984e-01 | 0.465 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.454810e-01 | 0.462 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.489689e-01 | 0.457 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.489689e-01 | 0.457 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.489689e-01 | 0.457 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.561031e-01 | 0.448 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.561031e-01 | 0.448 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.631595e-01 | 0.440 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.631595e-01 | 0.440 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.631595e-01 | 0.440 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.631595e-01 | 0.440 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.653495e-01 | 0.437 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.701391e-01 | 0.432 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.701391e-01 | 0.432 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.701391e-01 | 0.432 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.701391e-01 | 0.432 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.725093e-01 | 0.429 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.742045e-01 | 0.427 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.770425e-01 | 0.424 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.770425e-01 | 0.424 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.770425e-01 | 0.424 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.770425e-01 | 0.424 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.770425e-01 | 0.424 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.803168e-01 | 0.420 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.838708e-01 | 0.416 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.838708e-01 | 0.416 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.838708e-01 | 0.416 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.838708e-01 | 0.416 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.838708e-01 | 0.416 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.920721e-01 | 0.407 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 3.958077e-01 | 0.403 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.973048e-01 | 0.401 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.973048e-01 | 0.401 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 3.973048e-01 | 0.401 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.973048e-01 | 0.401 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.973048e-01 | 0.401 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.973048e-01 | 0.401 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.039121e-01 | 0.394 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.039121e-01 | 0.394 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.039121e-01 | 0.394 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.092819e-01 | 0.388 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.104475e-01 | 0.387 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.104475e-01 | 0.387 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.104475e-01 | 0.387 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.104475e-01 | 0.387 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.104475e-01 | 0.387 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.111209e-01 | 0.386 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.149198e-01 | 0.382 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.169116e-01 | 0.380 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.169116e-01 | 0.380 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.169116e-01 | 0.380 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.169116e-01 | 0.380 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.169116e-01 | 0.380 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.233052e-01 | 0.373 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.233052e-01 | 0.373 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.233052e-01 | 0.373 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 4.233052e-01 | 0.373 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.296291e-01 | 0.367 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.320590e-01 | 0.364 | 1 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.358840e-01 | 0.361 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.358840e-01 | 0.361 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.358840e-01 | 0.361 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.358840e-01 | 0.361 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.358840e-01 | 0.361 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.358840e-01 | 0.361 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.374517e-01 | 0.359 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.420707e-01 | 0.355 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.420707e-01 | 0.355 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.420707e-01 | 0.355 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.420707e-01 | 0.355 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.420707e-01 | 0.355 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.420707e-01 | 0.355 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.420707e-01 | 0.355 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.481900e-01 | 0.349 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.481900e-01 | 0.349 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.481900e-01 | 0.349 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.485417e-01 | 0.348 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.485417e-01 | 0.348 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.542425e-01 | 0.343 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.631366e-01 | 0.334 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 4.661502e-01 | 0.331 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.661502e-01 | 0.331 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.661502e-01 | 0.331 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.720068e-01 | 0.326 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.720068e-01 | 0.326 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.720068e-01 | 0.326 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.777995e-01 | 0.321 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.777995e-01 | 0.321 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.777995e-01 | 0.321 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.835290e-01 | 0.316 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.835290e-01 | 0.316 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.835290e-01 | 0.316 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.835290e-01 | 0.316 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.835290e-01 | 0.316 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.835290e-01 | 0.316 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.881266e-01 | 0.311 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.891960e-01 | 0.311 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.891960e-01 | 0.311 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.891960e-01 | 0.311 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.891960e-01 | 0.311 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.891960e-01 | 0.311 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.891960e-01 | 0.311 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.948012e-01 | 0.306 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.948012e-01 | 0.306 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.003452e-01 | 0.301 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.003452e-01 | 0.301 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 5.003452e-01 | 0.301 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.020794e-01 | 0.299 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.020794e-01 | 0.299 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.058287e-01 | 0.296 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.058287e-01 | 0.296 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.058287e-01 | 0.296 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.112524e-01 | 0.291 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.123833e-01 | 0.290 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.123833e-01 | 0.290 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.166168e-01 | 0.287 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 5.167748e-01 | 0.287 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.219228e-01 | 0.282 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.271708e-01 | 0.278 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.271708e-01 | 0.278 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 5.271708e-01 | 0.278 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.271708e-01 | 0.278 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.271708e-01 | 0.278 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.323615e-01 | 0.274 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.323615e-01 | 0.274 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.323615e-01 | 0.274 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.325691e-01 | 0.274 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.374955e-01 | 0.270 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.374955e-01 | 0.270 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.374955e-01 | 0.270 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.374955e-01 | 0.270 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.425735e-01 | 0.266 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.425735e-01 | 0.266 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.425735e-01 | 0.266 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.475961e-01 | 0.262 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.475961e-01 | 0.262 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.489530e-01 | 0.260 | 0 | 0 |
| Translation | R-HSA-72766 | 5.524122e-01 | 0.258 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.585897e-01 | 0.253 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 5.585897e-01 | 0.253 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.623371e-01 | 0.250 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.623371e-01 | 0.250 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.649329e-01 | 0.248 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.671439e-01 | 0.246 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.671439e-01 | 0.246 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.712109e-01 | 0.243 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.766004e-01 | 0.239 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.766004e-01 | 0.239 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.766004e-01 | 0.239 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.766004e-01 | 0.239 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.812514e-01 | 0.236 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.812514e-01 | 0.236 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.812514e-01 | 0.236 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.812514e-01 | 0.236 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.858516e-01 | 0.232 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.858516e-01 | 0.232 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.896517e-01 | 0.229 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.904015e-01 | 0.229 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.904015e-01 | 0.229 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.904015e-01 | 0.229 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.904015e-01 | 0.229 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 5.904015e-01 | 0.229 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.949017e-01 | 0.226 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.949017e-01 | 0.226 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.993527e-01 | 0.222 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.037551e-01 | 0.219 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.124161e-01 | 0.213 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.124161e-01 | 0.213 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.166757e-01 | 0.210 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.208888e-01 | 0.207 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.250559e-01 | 0.204 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.260893e-01 | 0.203 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.291774e-01 | 0.201 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.303804e-01 | 0.200 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.332538e-01 | 0.198 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.372857e-01 | 0.196 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.412735e-01 | 0.193 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.452178e-01 | 0.190 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.491189e-01 | 0.188 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.500591e-01 | 0.187 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.507452e-01 | 0.187 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.529773e-01 | 0.185 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.567935e-01 | 0.183 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.567935e-01 | 0.183 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.601358e-01 | 0.180 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.605680e-01 | 0.180 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.643013e-01 | 0.178 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.643013e-01 | 0.178 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.653362e-01 | 0.177 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.679125e-01 | 0.175 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.752577e-01 | 0.171 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.893151e-01 | 0.162 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.893151e-01 | 0.162 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 6.927339e-01 | 0.159 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.927339e-01 | 0.159 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.927339e-01 | 0.159 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.994596e-01 | 0.155 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 6.994596e-01 | 0.155 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.060389e-01 | 0.151 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.060389e-01 | 0.151 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.092746e-01 | 0.149 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.093056e-01 | 0.149 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.116018e-01 | 0.148 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.124749e-01 | 0.147 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.124749e-01 | 0.147 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.124749e-01 | 0.147 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 7.156402e-01 | 0.145 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.187708e-01 | 0.143 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.250636e-01 | 0.140 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.250636e-01 | 0.140 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.279586e-01 | 0.138 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.287734e-01 | 0.137 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.293690e-01 | 0.137 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.293690e-01 | 0.137 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.309543e-01 | 0.136 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.337420e-01 | 0.134 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.339173e-01 | 0.134 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.339173e-01 | 0.134 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.339173e-01 | 0.134 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.358751e-01 | 0.133 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 7.368478e-01 | 0.133 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.379937e-01 | 0.132 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.454481e-01 | 0.128 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.454481e-01 | 0.128 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.537689e-01 | 0.123 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 7.540606e-01 | 0.123 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.564199e-01 | 0.121 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.618192e-01 | 0.118 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.618192e-01 | 0.118 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.618192e-01 | 0.118 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.644441e-01 | 0.117 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 7.792493e-01 | 0.108 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.868101e-01 | 0.104 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.876223e-01 | 0.104 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.901532e-01 | 0.102 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 8.027348e-01 | 0.095 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.027348e-01 | 0.095 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.049110e-01 | 0.094 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.049110e-01 | 0.094 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.174761e-01 | 0.088 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 8.194906e-01 | 0.086 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.194906e-01 | 0.086 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.194906e-01 | 0.086 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.254024e-01 | 0.083 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.254024e-01 | 0.083 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.311216e-01 | 0.080 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.311216e-01 | 0.080 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.320009e-01 | 0.080 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.384585e-01 | 0.077 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.402426e-01 | 0.076 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.437523e-01 | 0.074 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.463850e-01 | 0.072 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.471853e-01 | 0.072 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.505433e-01 | 0.070 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 8.517765e-01 | 0.070 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.521947e-01 | 0.069 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.554433e-01 | 0.068 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.570408e-01 | 0.067 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.586208e-01 | 0.066 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.601834e-01 | 0.065 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.662640e-01 | 0.062 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.706513e-01 | 0.060 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.762790e-01 | 0.057 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.868145e-01 | 0.052 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.903338e-01 | 0.050 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.941262e-01 | 0.049 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.964575e-01 | 0.047 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.987377e-01 | 0.046 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.999996e-01 | 0.046 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.042222e-01 | 0.044 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.114077e-01 | 0.040 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.123894e-01 | 0.040 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.133604e-01 | 0.039 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.143206e-01 | 0.039 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.306807e-01 | 0.031 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.381244e-01 | 0.028 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.386905e-01 | 0.027 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.401524e-01 | 0.027 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.413691e-01 | 0.026 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.440913e-01 | 0.025 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.456217e-01 | 0.024 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.481499e-01 | 0.023 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.504413e-01 | 0.022 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.540367e-01 | 0.020 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.571269e-01 | 0.019 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.633458e-01 | 0.016 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.669123e-01 | 0.015 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.697031e-01 | 0.013 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.713095e-01 | 0.013 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.792385e-01 | 0.009 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.819240e-01 | 0.008 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.914319e-01 | 0.004 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.928280e-01 | 0.003 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.932222e-01 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.950628e-01 | 0.002 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.951122e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.962549e-01 | 0.002 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.992283e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.994027e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.994195e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999911e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.554312e-15 | 14.808 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.609024e-14 | 13.584 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.130030e-14 | 13.384 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.147971e-13 | 12.940 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.147971e-13 | 12.940 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.153833e-13 | 12.667 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.157474e-13 | 12.501 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.157474e-13 | 12.501 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.181411e-13 | 12.286 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.833423e-13 | 12.165 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.163514e-12 | 11.934 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.163514e-12 | 11.934 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.929679e-12 | 11.715 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.208012e-12 | 11.656 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.462586e-12 | 11.609 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.462586e-12 | 11.609 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.686407e-12 | 11.571 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.125056e-12 | 11.505 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.831380e-12 | 11.417 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.831380e-12 | 11.417 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.952039e-12 | 11.305 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.952039e-12 | 11.305 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.186607e-12 | 11.209 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.186607e-12 | 11.209 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.676371e-12 | 11.014 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.520496e-12 | 11.021 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.520496e-12 | 11.021 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.173162e-11 | 10.931 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.240341e-11 | 10.906 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.324751e-11 | 10.878 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.759193e-11 | 10.755 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.759193e-11 | 10.755 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.141431e-11 | 10.669 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.137857e-11 | 10.503 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.422807e-11 | 10.266 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.465639e-11 | 10.189 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.253642e-11 | 10.139 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.359913e-11 | 10.078 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.108525e-11 | 10.041 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.076419e-10 | 9.968 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.089080e-10 | 9.963 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.747861e-10 | 9.757 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.043818e-10 | 9.690 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.384042e-10 | 9.623 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.220969e-10 | 9.492 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.220969e-10 | 9.492 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.014851e-10 | 9.396 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.530040e-10 | 9.344 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.725884e-10 | 9.242 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.163468e-10 | 9.210 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.577547e-10 | 9.182 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.311454e-10 | 9.136 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.243233e-10 | 9.140 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.541126e-10 | 9.123 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.668767e-10 | 9.062 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.856449e-10 | 9.006 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.856449e-10 | 9.006 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.016121e-09 | 8.993 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.123763e-09 | 8.949 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.410152e-09 | 8.851 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.855479e-09 | 8.732 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.855479e-09 | 8.732 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.855479e-09 | 8.732 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.110245e-09 | 8.676 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.153275e-09 | 8.667 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.520091e-09 | 8.599 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.520327e-09 | 8.599 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.684959e-09 | 8.571 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.914549e-09 | 8.535 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.395927e-09 | 8.469 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.918094e-09 | 8.407 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.810977e-09 | 8.419 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.810977e-09 | 8.419 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.270818e-09 | 8.369 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.357739e-09 | 8.361 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.284964e-09 | 8.082 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.123850e-08 | 7.949 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.180737e-08 | 7.928 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.190514e-08 | 7.924 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.519207e-08 | 7.818 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.752805e-08 | 7.756 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.002244e-08 | 7.698 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.105686e-08 | 7.677 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.133057e-08 | 7.671 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.324260e-08 | 7.634 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.699387e-08 | 7.569 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.717420e-08 | 7.566 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.184068e-08 | 7.497 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.245798e-08 | 7.372 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.942730e-08 | 7.306 | 1 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.513540e-08 | 7.259 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.513540e-08 | 7.259 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.300851e-08 | 7.201 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.682794e-08 | 7.175 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.055314e-07 | 6.977 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.164319e-07 | 6.934 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.401088e-07 | 6.854 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.275128e-07 | 6.894 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.251585e-07 | 6.903 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.461818e-07 | 6.835 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.512021e-07 | 6.820 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.978318e-07 | 6.704 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.104431e-07 | 6.677 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.465782e-07 | 6.608 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.733079e-07 | 6.563 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.835762e-07 | 6.547 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.987604e-07 | 6.525 | 1 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.043094e-07 | 6.517 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.353013e-07 | 6.475 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.517170e-07 | 6.454 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.517170e-07 | 6.454 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.517170e-07 | 6.454 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.197485e-07 | 6.377 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.427970e-07 | 6.354 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.570471e-07 | 6.340 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.774154e-07 | 6.321 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.523161e-07 | 6.258 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.674909e-07 | 6.246 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.142233e-06 | 5.942 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.367468e-06 | 5.864 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.610139e-06 | 5.793 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.403796e-06 | 5.619 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.540133e-06 | 5.595 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.795244e-06 | 5.554 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.809105e-06 | 5.551 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.990695e-06 | 5.524 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.160123e-06 | 5.500 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.329294e-06 | 5.478 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.329294e-06 | 5.478 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.556049e-06 | 5.255 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.152505e-06 | 5.211 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.682075e-06 | 5.175 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.012364e-06 | 5.096 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.913982e-06 | 5.004 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.342212e-05 | 4.872 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.452828e-05 | 4.838 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.485738e-05 | 4.828 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.833931e-05 | 4.737 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.139589e-05 | 4.670 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.425316e-05 | 4.615 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.919203e-05 | 4.535 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.190642e-05 | 4.496 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.256583e-05 | 4.487 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.079247e-05 | 4.389 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.363478e-05 | 4.271 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.441835e-05 | 4.264 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.292787e-05 | 4.137 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.298463e-05 | 4.137 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.964212e-05 | 4.099 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.604474e-05 | 4.018 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.159386e-05 | 4.038 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.177257e-04 | 3.929 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.177257e-04 | 3.929 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.367092e-04 | 3.864 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.470691e-04 | 3.832 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.697892e-04 | 3.770 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.709643e-04 | 3.767 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.866528e-04 | 3.729 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.085716e-04 | 3.681 | 1 | 1 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.094747e-04 | 3.679 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.230009e-04 | 3.652 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.283464e-04 | 3.641 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.382052e-04 | 3.623 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.710571e-04 | 3.567 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.887648e-04 | 3.539 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.909276e-04 | 3.536 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.909276e-04 | 3.536 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.909276e-04 | 3.536 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.909276e-04 | 3.536 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.963932e-04 | 3.528 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.033383e-04 | 3.518 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.761436e-04 | 3.425 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.344324e-04 | 3.362 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.654016e-04 | 3.332 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.685760e-04 | 3.329 | 1 | 1 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.501783e-04 | 3.259 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.125564e-04 | 3.213 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.631709e-04 | 3.249 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.787038e-04 | 3.238 | 1 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.774322e-04 | 3.238 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.805757e-04 | 3.236 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.443747e-04 | 3.128 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.157081e-04 | 3.088 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.942011e-04 | 3.049 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.608945e-04 | 3.017 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.914019e-04 | 3.004 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.116537e-03 | 2.952 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.120238e-03 | 2.951 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.165795e-03 | 2.933 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.277574e-03 | 2.894 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.336219e-03 | 2.874 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.458558e-03 | 2.836 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.576443e-03 | 2.802 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.674222e-03 | 2.776 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.804308e-03 | 2.744 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.852795e-03 | 2.732 | 1 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.858354e-03 | 2.731 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.887179e-03 | 2.724 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.920639e-03 | 2.717 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.929376e-03 | 2.715 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.929376e-03 | 2.715 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.939774e-03 | 2.712 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.996408e-03 | 2.700 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.996664e-03 | 2.700 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.998434e-03 | 2.699 | 1 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.029565e-03 | 2.693 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.297480e-03 | 2.639 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.435301e-03 | 2.613 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.435301e-03 | 2.613 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.440141e-03 | 2.613 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.516244e-03 | 2.599 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.713457e-03 | 2.566 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.723944e-03 | 2.565 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.971913e-03 | 2.527 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.181838e-03 | 2.497 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.215237e-03 | 2.493 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.637668e-03 | 2.439 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.607662e-03 | 2.337 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.110336e-03 | 2.292 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.136601e-03 | 2.383 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.807395e-03 | 2.318 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.807395e-03 | 2.318 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.072640e-03 | 2.390 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.110336e-03 | 2.292 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.144960e-03 | 2.289 | 1 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.882693e-03 | 2.411 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.280185e-03 | 2.277 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.038024e-03 | 2.219 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.141270e-03 | 2.212 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.396357e-03 | 2.194 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.609019e-03 | 2.180 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.609019e-03 | 2.180 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.609019e-03 | 2.180 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.638101e-03 | 2.178 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.925013e-03 | 2.160 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.258740e-03 | 2.139 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.258740e-03 | 2.139 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.460846e-03 | 2.073 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.189100e-03 | 2.037 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.719846e-03 | 2.012 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.022475e-02 | 1.990 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.044038e-02 | 1.981 | 1 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.044038e-02 | 1.981 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.044038e-02 | 1.981 | 1 | 1 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.044038e-02 | 1.981 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.044038e-02 | 1.981 | 1 | 1 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.044038e-02 | 1.981 | 1 | 1 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.044038e-02 | 1.981 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.044038e-02 | 1.981 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.044038e-02 | 1.981 | 1 | 1 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.044038e-02 | 1.981 | 1 | 1 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.044038e-02 | 1.981 | 1 | 1 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.044038e-02 | 1.981 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.044038e-02 | 1.981 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.044038e-02 | 1.981 | 1 | 1 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.044038e-02 | 1.981 | 1 | 1 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.045337e-02 | 1.981 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.089852e-02 | 1.963 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.111153e-02 | 1.954 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.135141e-02 | 1.945 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.206383e-02 | 1.919 | 1 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.295890e-02 | 1.887 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.407873e-02 | 1.851 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.425456e-02 | 1.846 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.483286e-02 | 1.829 | 1 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.567659e-02 | 1.805 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.567659e-02 | 1.805 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.721201e-02 | 1.764 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.734832e-02 | 1.761 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.734832e-02 | 1.761 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.760977e-02 | 1.754 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.909221e-02 | 1.719 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.909221e-02 | 1.719 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.278984e-02 | 1.642 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.813049e-02 | 1.551 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.048156e-02 | 1.516 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.090660e-02 | 1.680 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.675643e-02 | 1.573 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.883662e-02 | 1.540 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.048156e-02 | 1.516 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.675643e-02 | 1.573 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.114914e-02 | 1.675 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.058295e-02 | 1.515 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.107390e-02 | 1.676 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.699090e-02 | 1.569 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.278984e-02 | 1.642 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.883662e-02 | 1.540 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.048156e-02 | 1.516 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.048156e-02 | 1.516 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.090660e-02 | 1.680 | 1 | 1 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.759634e-02 | 1.559 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.883662e-02 | 1.540 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.542800e-02 | 1.595 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.278984e-02 | 1.642 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.099717e-02 | 1.509 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.099717e-02 | 1.509 | 1 | 1 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.099717e-02 | 1.509 | 1 | 1 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.099717e-02 | 1.509 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.099717e-02 | 1.509 | 1 | 1 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.099717e-02 | 1.509 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.282345e-02 | 1.484 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.293301e-02 | 1.482 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.318311e-02 | 1.479 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.318311e-02 | 1.479 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.318311e-02 | 1.479 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.544639e-02 | 1.450 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.776774e-02 | 1.423 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.776774e-02 | 1.423 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.111581e-02 | 1.386 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.111581e-02 | 1.386 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.111581e-02 | 1.386 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.111581e-02 | 1.386 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.111581e-02 | 1.386 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.111581e-02 | 1.386 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.257886e-02 | 1.371 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.257886e-02 | 1.371 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.257886e-02 | 1.371 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.506582e-02 | 1.346 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.667234e-02 | 1.331 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.760522e-02 | 1.322 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.760522e-02 | 1.322 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.795044e-02 | 1.319 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.959256e-02 | 1.305 | 1 | 1 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.971051e-02 | 1.304 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.019568e-02 | 1.299 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.112940e-02 | 1.291 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.112940e-02 | 1.291 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.112940e-02 | 1.291 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.134747e-02 | 1.289 | 1 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.552456e-02 | 1.256 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.552456e-02 | 1.256 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.826037e-02 | 1.235 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.103903e-02 | 1.214 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.104207e-02 | 1.214 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.279364e-02 | 1.202 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.386841e-02 | 1.195 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.386841e-02 | 1.195 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.386841e-02 | 1.195 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.386841e-02 | 1.195 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.425437e-02 | 1.192 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.453100e-02 | 1.190 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.754520e-02 | 1.170 | 1 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 6.945635e-02 | 1.158 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.965018e-02 | 1.157 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.965018e-02 | 1.157 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.965018e-02 | 1.157 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.084578e-02 | 1.150 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.449976e-02 | 1.128 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.055070e-02 | 1.094 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 8.055070e-02 | 1.094 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.965926e-02 | 1.001 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.965926e-02 | 1.001 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.965926e-02 | 1.001 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.965926e-02 | 1.001 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.090650e-01 | 0.962 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.090650e-01 | 0.962 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.183730e-01 | 0.927 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.183730e-01 | 0.927 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.275844e-01 | 0.894 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.275844e-01 | 0.894 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.367000e-01 | 0.864 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.108365e-01 | 0.955 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.079827e-01 | 0.967 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.350737e-01 | 0.869 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.183730e-01 | 0.927 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.168577e-01 | 0.932 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.090650e-01 | 0.962 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.275844e-01 | 0.894 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.367000e-01 | 0.864 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.353840e-01 | 0.868 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.275844e-01 | 0.894 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.559611e-02 | 1.122 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.307900e-02 | 1.081 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.074763e-01 | 0.969 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.113746e-02 | 1.091 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.965926e-02 | 1.001 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.090650e-01 | 0.962 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.183730e-01 | 0.927 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.055070e-02 | 1.094 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.074763e-01 | 0.969 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 8.055070e-02 | 1.094 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.183730e-01 | 0.927 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.367000e-01 | 0.864 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.367000e-01 | 0.864 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.457210e-01 | 0.836 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.169701e-02 | 1.088 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.111947e-02 | 1.040 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.728226e-02 | 1.012 | 1 | 1 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.183730e-01 | 0.927 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.280299e-01 | 0.893 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.169701e-02 | 1.088 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.090650e-01 | 0.962 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.183730e-01 | 0.927 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.275844e-01 | 0.894 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.457210e-01 | 0.836 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.794394e-02 | 1.056 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.330146e-01 | 0.876 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.330146e-01 | 0.876 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.559611e-02 | 1.122 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.067277e-02 | 1.043 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.494092e-01 | 0.826 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.210777e-01 | 0.917 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.794394e-02 | 1.056 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.313034e-02 | 1.031 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 1.090650e-01 | 0.962 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.457210e-01 | 0.836 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.142241e-01 | 0.942 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.315408e-01 | 0.881 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.055070e-02 | 1.094 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.055070e-02 | 1.094 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.015485e-02 | 1.045 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.183730e-01 | 0.927 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.041444e-01 | 0.982 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.041444e-01 | 0.982 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.153416e-01 | 0.938 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.169701e-02 | 1.088 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.183730e-01 | 0.927 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.210777e-01 | 0.917 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.199437e-01 | 0.921 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.425786e-01 | 0.846 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.367000e-01 | 0.864 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.169701e-02 | 1.088 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.407231e-01 | 0.852 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.414302e-01 | 0.849 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.123863e-01 | 0.949 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.146137e-01 | 0.941 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.494092e-01 | 0.826 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.236879e-01 | 0.908 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.018415e-01 | 0.992 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.183730e-01 | 0.927 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.051444e-01 | 0.978 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.420049e-01 | 0.848 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.127379e-01 | 0.948 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.905441e-02 | 1.050 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.176382e-01 | 0.929 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.245420e-01 | 0.905 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.367000e-01 | 0.864 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.008418e-01 | 0.996 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.041444e-01 | 0.982 | 1 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.058069e-01 | 0.975 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.108365e-01 | 0.955 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.498983e-01 | 0.824 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.546483e-01 | 0.811 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.546483e-01 | 0.811 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.546483e-01 | 0.811 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.546483e-01 | 0.811 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.546483e-01 | 0.811 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 1.546483e-01 | 0.811 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.546483e-01 | 0.811 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.546483e-01 | 0.811 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.546483e-01 | 0.811 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.573366e-01 | 0.803 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.573366e-01 | 0.803 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.598413e-01 | 0.796 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.603527e-01 | 0.795 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.634828e-01 | 0.787 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.634828e-01 | 0.787 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.634828e-01 | 0.787 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.634828e-01 | 0.787 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.640331e-01 | 0.785 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.640331e-01 | 0.785 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.677285e-01 | 0.775 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.722255e-01 | 0.764 | 1 | 1 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.722255e-01 | 0.764 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.722255e-01 | 0.764 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.722255e-01 | 0.764 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.751183e-01 | 0.757 | 1 | 1 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.777038e-01 | 0.750 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.808774e-01 | 0.743 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.808774e-01 | 0.743 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.808774e-01 | 0.743 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.808774e-01 | 0.743 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.808774e-01 | 0.743 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.808774e-01 | 0.743 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.808774e-01 | 0.743 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.808774e-01 | 0.743 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.808774e-01 | 0.743 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.855229e-01 | 0.732 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.864067e-01 | 0.730 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.894394e-01 | 0.723 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.894394e-01 | 0.723 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.894394e-01 | 0.723 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.901779e-01 | 0.721 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.979125e-01 | 0.704 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.979125e-01 | 0.704 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.979125e-01 | 0.704 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.979125e-01 | 0.704 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.014229e-01 | 0.696 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.015510e-01 | 0.696 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.015510e-01 | 0.696 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.062975e-01 | 0.686 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.062975e-01 | 0.686 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.091767e-01 | 0.679 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.145953e-01 | 0.668 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.145953e-01 | 0.668 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.145953e-01 | 0.668 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.145953e-01 | 0.668 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.145953e-01 | 0.668 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.168317e-01 | 0.664 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.206689e-01 | 0.656 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.228069e-01 | 0.652 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.258369e-01 | 0.646 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.283597e-01 | 0.641 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.309331e-01 | 0.637 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.309331e-01 | 0.637 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.309331e-01 | 0.637 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.360690e-01 | 0.627 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.366482e-01 | 0.626 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.368689e-01 | 0.625 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.388946e-01 | 0.622 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.389749e-01 | 0.622 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.389749e-01 | 0.622 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.389749e-01 | 0.622 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.389749e-01 | 0.622 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.437928e-01 | 0.613 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.469331e-01 | 0.607 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.469331e-01 | 0.607 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.469331e-01 | 0.607 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.469331e-01 | 0.607 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.548085e-01 | 0.594 | 1 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.548085e-01 | 0.594 | 1 | 1 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.548085e-01 | 0.594 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.548085e-01 | 0.594 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.548085e-01 | 0.594 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.553320e-01 | 0.593 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.592682e-01 | 0.586 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.592682e-01 | 0.586 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.592682e-01 | 0.586 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.626021e-01 | 0.581 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.626021e-01 | 0.581 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.626021e-01 | 0.581 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.626021e-01 | 0.581 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.626021e-01 | 0.581 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.703146e-01 | 0.568 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.703146e-01 | 0.568 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.703146e-01 | 0.568 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.703146e-01 | 0.568 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.703146e-01 | 0.568 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.703146e-01 | 0.568 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.703146e-01 | 0.568 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.708849e-01 | 0.567 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.761257e-01 | 0.559 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.779470e-01 | 0.556 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.779470e-01 | 0.556 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.779470e-01 | 0.556 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.779470e-01 | 0.556 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.779470e-01 | 0.556 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.789588e-01 | 0.554 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.854999e-01 | 0.544 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.854999e-01 | 0.544 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.854999e-01 | 0.544 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.874743e-01 | 0.541 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.929744e-01 | 0.533 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.929744e-01 | 0.533 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.929744e-01 | 0.533 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.929744e-01 | 0.533 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.929744e-01 | 0.533 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.940945e-01 | 0.532 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.979551e-01 | 0.526 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.988599e-01 | 0.525 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.003711e-01 | 0.522 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.003711e-01 | 0.522 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.003711e-01 | 0.522 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.003711e-01 | 0.522 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.003711e-01 | 0.522 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.076908e-01 | 0.512 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.076908e-01 | 0.512 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.076908e-01 | 0.512 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.076908e-01 | 0.512 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.076908e-01 | 0.512 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.133624e-01 | 0.504 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.149345e-01 | 0.502 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.149345e-01 | 0.502 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.149345e-01 | 0.502 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.149345e-01 | 0.502 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.149345e-01 | 0.502 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.188398e-01 | 0.496 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.221027e-01 | 0.492 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.221027e-01 | 0.492 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.221027e-01 | 0.492 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.221027e-01 | 0.492 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.221027e-01 | 0.492 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.221027e-01 | 0.492 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.221027e-01 | 0.492 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.221027e-01 | 0.492 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.248714e-01 | 0.488 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.248714e-01 | 0.488 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.248714e-01 | 0.488 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.274125e-01 | 0.485 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.274125e-01 | 0.485 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.286971e-01 | 0.483 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.291965e-01 | 0.483 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.291965e-01 | 0.483 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.291965e-01 | 0.483 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.325171e-01 | 0.478 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.362164e-01 | 0.473 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.362164e-01 | 0.473 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.362164e-01 | 0.473 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.362164e-01 | 0.473 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.362164e-01 | 0.473 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.401385e-01 | 0.468 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.431633e-01 | 0.464 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.431633e-01 | 0.464 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.431633e-01 | 0.464 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.431633e-01 | 0.464 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.500379e-01 | 0.456 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.500379e-01 | 0.456 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.500379e-01 | 0.456 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.552993e-01 | 0.449 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.552993e-01 | 0.449 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.568410e-01 | 0.448 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.568410e-01 | 0.448 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.568410e-01 | 0.448 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.568410e-01 | 0.448 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.568410e-01 | 0.448 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.568410e-01 | 0.448 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.635733e-01 | 0.439 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.635733e-01 | 0.439 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.635733e-01 | 0.439 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.635733e-01 | 0.439 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.635733e-01 | 0.439 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.701880e-01 | 0.432 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.702355e-01 | 0.432 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.702355e-01 | 0.432 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.702355e-01 | 0.432 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.702355e-01 | 0.432 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.702355e-01 | 0.432 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.702355e-01 | 0.432 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 3.740749e-01 | 0.427 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.768284e-01 | 0.424 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.833527e-01 | 0.416 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.833527e-01 | 0.416 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.833527e-01 | 0.416 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.833527e-01 | 0.416 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.833527e-01 | 0.416 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.833527e-01 | 0.416 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.833527e-01 | 0.416 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.833527e-01 | 0.416 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.898091e-01 | 0.409 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.898091e-01 | 0.409 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.898091e-01 | 0.409 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.898091e-01 | 0.409 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.898091e-01 | 0.409 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.898091e-01 | 0.409 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.898091e-01 | 0.409 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.898091e-01 | 0.409 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.898091e-01 | 0.409 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.898091e-01 | 0.409 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.898091e-01 | 0.409 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.926281e-01 | 0.406 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.961982e-01 | 0.402 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.961982e-01 | 0.402 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.961982e-01 | 0.402 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.961982e-01 | 0.402 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.999810e-01 | 0.398 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.025209e-01 | 0.395 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.025209e-01 | 0.395 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.025209e-01 | 0.395 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 4.025209e-01 | 0.395 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.025209e-01 | 0.395 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.025209e-01 | 0.395 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.025209e-01 | 0.395 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.087778e-01 | 0.389 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.087778e-01 | 0.389 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.087778e-01 | 0.389 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 4.124711e-01 | 0.385 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.145613e-01 | 0.382 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.149695e-01 | 0.382 | 1 | 1 |
| Defensins | R-HSA-1461973 | 4.149695e-01 | 0.382 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.149695e-01 | 0.382 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.149695e-01 | 0.382 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.210967e-01 | 0.376 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.210967e-01 | 0.376 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.210967e-01 | 0.376 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.210967e-01 | 0.376 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.271602e-01 | 0.369 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.271602e-01 | 0.369 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.271602e-01 | 0.369 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.271602e-01 | 0.369 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.271602e-01 | 0.369 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.271602e-01 | 0.369 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.271602e-01 | 0.369 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.271602e-01 | 0.369 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.331605e-01 | 0.363 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.331605e-01 | 0.363 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.331605e-01 | 0.363 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.331605e-01 | 0.363 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.331605e-01 | 0.363 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.331605e-01 | 0.363 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.331605e-01 | 0.363 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.390983e-01 | 0.357 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.390983e-01 | 0.357 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.401813e-01 | 0.356 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.449743e-01 | 0.352 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.449743e-01 | 0.352 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.507891e-01 | 0.346 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.507891e-01 | 0.346 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.507891e-01 | 0.346 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.565433e-01 | 0.341 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.606757e-01 | 0.337 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 4.622376e-01 | 0.335 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.622376e-01 | 0.335 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.622376e-01 | 0.335 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.622376e-01 | 0.335 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.678726e-01 | 0.330 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.678726e-01 | 0.330 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.678726e-01 | 0.330 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.678726e-01 | 0.330 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.678726e-01 | 0.330 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.678726e-01 | 0.330 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.734489e-01 | 0.325 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.734489e-01 | 0.325 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.734489e-01 | 0.325 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.734489e-01 | 0.325 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.778486e-01 | 0.321 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.789671e-01 | 0.320 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.844278e-01 | 0.315 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.844278e-01 | 0.315 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.846247e-01 | 0.315 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.861051e-01 | 0.313 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.898316e-01 | 0.310 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.898316e-01 | 0.310 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.898316e-01 | 0.310 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.940024e-01 | 0.306 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.946870e-01 | 0.306 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.057075e-01 | 0.296 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.057075e-01 | 0.296 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.057075e-01 | 0.296 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.057075e-01 | 0.296 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.079097e-01 | 0.294 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.108895e-01 | 0.292 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.108895e-01 | 0.292 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.108895e-01 | 0.292 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.144367e-01 | 0.289 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.160176e-01 | 0.287 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.160176e-01 | 0.287 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.160176e-01 | 0.287 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.176789e-01 | 0.286 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.209068e-01 | 0.283 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.210922e-01 | 0.283 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.210922e-01 | 0.283 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.210922e-01 | 0.283 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.210922e-01 | 0.283 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.210922e-01 | 0.283 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.241203e-01 | 0.281 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.261139e-01 | 0.279 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.261139e-01 | 0.279 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.261139e-01 | 0.279 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.261139e-01 | 0.279 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.273195e-01 | 0.278 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.310832e-01 | 0.275 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.310832e-01 | 0.275 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.336743e-01 | 0.273 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.360008e-01 | 0.271 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.368300e-01 | 0.270 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.430975e-01 | 0.265 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.456826e-01 | 0.263 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.504479e-01 | 0.259 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.598300e-01 | 0.252 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.598300e-01 | 0.252 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.598300e-01 | 0.252 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.598300e-01 | 0.252 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.644478e-01 | 0.248 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.644478e-01 | 0.248 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.644478e-01 | 0.248 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.650940e-01 | 0.248 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.690174e-01 | 0.245 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.690174e-01 | 0.245 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.735394e-01 | 0.241 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.735394e-01 | 0.241 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.780142e-01 | 0.238 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.868242e-01 | 0.231 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.954514e-01 | 0.225 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.954514e-01 | 0.225 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.954514e-01 | 0.225 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.038995e-01 | 0.219 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.038995e-01 | 0.219 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.080576e-01 | 0.216 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.162439e-01 | 0.210 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.162439e-01 | 0.210 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.164289e-01 | 0.210 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.202731e-01 | 0.207 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.242603e-01 | 0.205 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.282058e-01 | 0.202 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.321102e-01 | 0.199 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.359738e-01 | 0.197 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.359738e-01 | 0.197 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.435803e-01 | 0.191 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.473242e-01 | 0.189 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.483101e-01 | 0.188 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.619125e-01 | 0.179 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.724587e-01 | 0.172 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.724587e-01 | 0.172 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.756687e-01 | 0.170 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.759009e-01 | 0.170 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.826778e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.826778e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.826778e-01 | 0.166 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.826778e-01 | 0.166 | 0 | 0 |
| Translation | R-HSA-72766 | 6.976886e-01 | 0.156 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.021747e-01 | 0.154 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.084053e-01 | 0.150 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.084053e-01 | 0.150 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.114718e-01 | 0.148 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.145063e-01 | 0.146 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.145388e-01 | 0.146 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.175090e-01 | 0.144 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.175090e-01 | 0.144 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.175090e-01 | 0.144 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.204803e-01 | 0.142 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.234206e-01 | 0.141 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.234206e-01 | 0.141 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.263301e-01 | 0.139 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.320582e-01 | 0.135 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.325579e-01 | 0.135 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.333728e-01 | 0.135 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.375658e-01 | 0.132 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.385604e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.404276e-01 | 0.131 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.431592e-01 | 0.129 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.485371e-01 | 0.126 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.533084e-01 | 0.123 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.538030e-01 | 0.123 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.538030e-01 | 0.123 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.538030e-01 | 0.123 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.589592e-01 | 0.120 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.589592e-01 | 0.120 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.614969e-01 | 0.118 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.614969e-01 | 0.118 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.713850e-01 | 0.113 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.718436e-01 | 0.112 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.785326e-01 | 0.109 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.007914e-01 | 0.096 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.049687e-01 | 0.094 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.068703e-01 | 0.093 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.196582e-01 | 0.086 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.245845e-01 | 0.084 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.264348e-01 | 0.083 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.264348e-01 | 0.083 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.292759e-01 | 0.081 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.300773e-01 | 0.081 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.318699e-01 | 0.080 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.336438e-01 | 0.079 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.439030e-01 | 0.074 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.448679e-01 | 0.073 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.471809e-01 | 0.072 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.581241e-01 | 0.066 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.640238e-01 | 0.063 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.654603e-01 | 0.063 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.710566e-01 | 0.060 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.751015e-01 | 0.058 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.852816e-01 | 0.053 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.888826e-01 | 0.051 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.042568e-01 | 0.044 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.131933e-01 | 0.039 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.217932e-01 | 0.035 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.354481e-01 | 0.029 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.481743e-01 | 0.023 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.505681e-01 | 0.022 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.574380e-01 | 0.019 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.592202e-01 | 0.018 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.792479e-01 | 0.009 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.863505e-01 | 0.006 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.878752e-01 | 0.005 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.882609e-01 | 0.005 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.985356e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.985608e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.989331e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.993593e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999999e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
